«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:

期数:

2024年10期

页码:

45-49

栏目:

出版日期:

2024-09-26

文章信息/Info

Title:

Analysis of the Clinical Effect of Photodynamic Combination Therapy in the

文章编号:

1008-6455（2024）10-0045-05

作者:

宋红娟1; 马国安1; 闫婷2; 刘丽丽3;  丁红炜1

(1.衡水市人民医院皮肤科 河北 衡水 053000;2.衡水市人民医院胸外科 河北 衡水 053000;3.衡水市第四人民医院耳鼻喉 科 河北 衡水 053000)

Author(s):

SONG Hongjuan1 ;  MA Guo’an1 ;  YAN Ting2 ;  LIU Lili3 ;  DING Hongwei1

( 1. Department of Dermatology, Hengshui People’s Hospital, Hengshui 053000, Hebei, China; 2. Department of chest surger, Hengshui People’s Hospital, Hengshui 053000, Hebei, China; 3.Department of Otolaryngology, the Fourth People’s Hospital of Hengshui, Hengshui 053000, Hebei, China)

关键词:

玫瑰痤疮; 5-氨基酮戊酸光动力; 克林霉素甲硝唑搽剂; 皮肤屏障功能; 干扰素-γ; 白介素-17; 联合疗法

Keywords:

rosacea;  5-aminolevulinic acid photodynamic therapy;  clindamycin metronidazole liniment;  skin barrier function

分类号:

R758.73+ 4

文献标志码:

A

摘要:

目的：观察光动力联合疗法治疗玫瑰痤疮的临床疗效。患者。采用随机数字表法分为研究组、对照组，各100例，并根据分型分为红斑毛细血管扩张型、丘疹脓疱型两个亚组。对照 组给予外用克林霉素甲硝唑搽剂及医用愈肤生物膜治疗，研究组在对照组基础上给予5-氨基酮戊酸光动力疗法。比较两组治疗 前、治疗4周后临床症状评分、皮损部位角质层含水量、经皮水丢失量（Trans epidermal water loss, TEWL）、血清白介素-17 （IL-17）、干扰素-γ（IFN-γ）水平，记录两组疗效、蠕形螨转阴率、不良反应。结果：两种亚型研究组总有效率、蠕形螨 转阴率均高于对照组（P＜0.05）；治疗4周后，两种亚型研究组临床症状评分均低于对照组（P＜0.05）；治疗4周后，两种亚 型研究组角质层含水量均高于对照组，TEWL均低于对照组（P＜0.05）；治疗4周后，两种亚型研究组血清IL-17、IFN-γ水平 均低于对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论：光动力联合疗法治疗红斑毛细 血管扩张型、丘疹脓疱型玫瑰痤疮，可减轻临床症状，降低炎症因子表达，改善皮肤屏障功能，有效驱除蠕形螨，效果显著。

Abstract:

Objective To observe the clinical effect of photodynamic combination therapy on rosacea. Methods A total of 200 patients with rosacea treated at the author’s hospital from January 2022 to January 2023 were selected for the study. They were randomly divided into two groups, the study group and the control group, with 100 patients in each group. Both groups were further subdivided into erythema telangiectatic type and papulopustular type. The control group was treated with topical clindamycin metronidazole liniment and a medical skin healing biofi lm. The study group received 5-aminolevulinic acid photodynamic therapy in addition to the treatment given to the control group. Clinical symptom scores, stratum corneum hydration, transepidermal water loss (TEWL), and serum levels of interleukin-17 (IL-17) and interferon-gamma (IFN-γ) were compared between the two groups before treatment and 4 weeks after treatment. The treatment effi cacy, Demodex negative conversion rate, and incidence of adverse reactions were recorded in both groups. Results The total eff ective rate and Demodex negative conversion rate in both subtypes of the study group were higher than those in the control group (P＜0.05). After 4 weeks of treatment, clinical symptom scores in both subtypes of the study group were lower than those in the control group (P＜0.05). The stratum corneum hydration in both subtypes of the study group was higher, and TEWL was lower, compared to the control group (P＜0.05). Serum levels of IL-17 and IFN-γ in both subtypes of the study group were lower than those in the control group after 4 weeks of treatment (P＜0.05). There was no significant difference in the incidence of adverse reactions between the two groups(P＞0.05). Conclusion Photodynamic combination therapy for erythema telangiectatic and papulopustular rosacea eff ectively reduces clinical symptoms, decreases infl ammatory factor expression, improves skin barrier function, and successfully eliminates Demodex, with signifi cant therapeutic benefi ts.

常用功能

更新日期/Last Update: 2024-09-30